Back to Treatments

Treatment

Induction Chemotherapy + Concurrent Chemoradiotherapy (Cisplatin-based)

1
Conditions
8
Trials
15K
Participants
20%
Average Safety

Condition Evidence

Nasopharynx cancer

8 trials · 15K participants

88% effectiveness · 20% safety
Induction Chemotherapy + Concurrent Chemoradiotherapy (Cisplatin-based) | DFDA